Rhinology Unit, Department of Otorhinolaryngology, Hospital de Sabadell, Institut Universitari Parc Taulí, Universitat Autònoma de Barcelona, Parc Taulí nº 1, 08028, Sabadell, Spain,
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1505-11. doi: 10.1007/s00405-013-2700-0. Epub 2013 Sep 20.
Significant bleeding during functional endoscopic naso-sinusal surgery (FESS) impairs recognition of anatomical references and may negatively affect surgical outcome. Through their hypotensive effect, adjuvant anaesthetic agents may influence intraoperative bleeding. The present study compared intraoperative bleeding in patients undergoing FESS administered a clonidine-based anaesthetic regimen and in patients receiving other an anaesthetic combination with higher acquisition costs. Prospective observational study included 37 subjects undergoing FESS in 2011. Assessment of intraoperative bleeding was according to type of anaesthesia (clonidine vs. opioid derivatives). Patients receiving clonidine (N = 11; 29.7%) presented significantly lower surgical field bleeding scores than those receiving opioid derivatives (N = 26; 70.3%) [mean (SD) Boezaart scores 1.91 (0.53) vs. 2.92 (0.79), p < 0.0001]. The multivariate analysis including baseline characteristics and risk factors related to bleeding intensity showed that the type of drug used for controlled hypotensive anaesthesia was the best predictor of bleeding during FESS, with an OR of 0.03 for clonidine based vs. opioid based anaesthesia (p = 0.014). The anaesthetic combination including clonidine for controlled hypotensive anaesthesia produces lower levels of surgical field bleeding during FESS. Compared with other hypotensive anaesthetics, clonidine is inexpensive and associated with better surgical conditions during FESS. If confirmed through randomized clinical trials, the use of clonidine during FESS can reduce surgical time and improve surgical results through a less bloody field, resulting in lower patient morbidity and improvement of operating room resources.
功能性内窥镜鼻窦手术(FESS)过程中大量出血会影响解剖学参考的识别,并可能对手术结果产生负面影响。辅助麻醉剂通过其降压作用可能会影响术中出血。本研究比较了在接受可乐定基础麻醉方案的 FESS 患者和接受其他具有更高购置成本的麻醉组合的患者的术中出血。2011 年进行前瞻性观察性研究,共纳入 37 例接受 FESS 的患者。术中出血的评估是根据麻醉类型(可乐定与阿片类衍生物)进行的。接受可乐定(N=11;29.7%)的患者的手术视野出血评分明显低于接受阿片类衍生物(N=26;70.3%)[Boezaart 评分的平均值(标准差)分别为 1.91(0.53)和 2.92(0.79),p<0.0001]。包括基线特征和与出血强度相关的风险因素的多变量分析表明,用于控制性降压麻醉的药物类型是 FESS 术中出血的最佳预测因素,与基于阿片类药物的麻醉相比,可乐定的比值比为 0.03(p=0.014)。包括可乐定用于控制性降压麻醉的麻醉组合可降低 FESS 术中手术视野出血。与其他降压麻醉剂相比,可乐定价格低廉,并且在 FESS 期间具有更好的手术条件。如果通过随机临床试验得到证实,FESS 中使用可乐定可减少手术时间并通过更清晰的手术视野改善手术结果,从而降低患者的发病率并改善手术室资源的利用。